购物车
- 全部删除
- 您的购物车当前为空
Pyr6 (N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide)是选择性的 TRPC3抑制剂,IC50值为0.49uM。
为众多的药物研发团队赋能,
让新药发现更简单!
Pyr6 (N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide)是选择性的 TRPC3抑制剂,IC50值为0.49uM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 173 | 现货 | |
5 mg | ¥ 437 | 现货 | |
10 mg | ¥ 642 | 现货 | |
25 mg | ¥ 1,070 | 现货 | |
50 mg | ¥ 1,600 | 现货 | |
100 mg | ¥ 2,350 | 现货 | |
200 mg | ¥ 3,370 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 470 | 现货 |
产品描述 | Pyr6 (N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide) is a selective TRPC3 inhibitor with IC50 of 0.49 uM(Ca2+ influx inhibition in thapsigargin depleted native RBL-2H3 cells).Pyr6 is an inhibitor of Ca2+ entry, which displays higher potency to inhibit Ca2+ entry mediated by CRAC channel than by TRPC3. |
靶点活性 | TRPC3:0.49 uM |
体外活性 | Pyr3 is selective inhibitor of TRPC3, inhibited Orai1- and TRPC3-mediated Ca(2+) entry and currents as well as mast cell activation with similar potency.?By contrast, Pyr6 exhibited a 37-fold higher potency to inhibit Orai1-mediated Ca(2+) entry as compared with TRPC3-mediated Ca(2+) entry and potently suppressed mast cell activation. |
别名 | N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide |
分子量 | 418.27 |
分子式 | C17H9F7N4O |
CAS No. | 245747-08-4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 95 mg/mL (227.12 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.